BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 29521482)

  • 21. PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status.
    Lütje S; Heskamp S; Cornelissen AS; Poeppel TD; van den Broek SA; Rosenbaum-Krumme S; Bockisch A; Gotthardt M; Rijpkema M; Boerman OC
    Theranostics; 2015; 5(12):1388-401. PubMed ID: 26681984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.
    Morigi JJ; Stricker PD; van Leeuwen PJ; Tang R; Ho B; Nguyen Q; Hruby G; Fogarty G; Jagavkar R; Kneebone A; Hickey A; Fanti S; Tarlinton L; Emmett L
    J Nucl Med; 2015 Aug; 56(8):1185-90. PubMed ID: 26112024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integration of PSMA-targeted PET imaging into the armamentarium for detecting clinically significant prostate cancer.
    Meyer AR; Joice GA; Allaf ME; Rowe SP; Gorin MA
    Curr Opin Urol; 2018 Nov; 28(6):493-498. PubMed ID: 30188333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.
    Jilg CA; Drendel V; Rischke HC; Beck T; Vach W; Schaal K; Wetterauer U; Schultze-Seemann W; Meyer PT
    Theranostics; 2017; 7(6):1770-1780. PubMed ID: 28529650
    [No Abstract]   [Full Text] [Related]  

  • 25. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
    van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD
    BJU Int; 2017 Feb; 119(2):209-215. PubMed ID: 27207581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PSMA Ligands for PET Imaging of Prostate Cancer.
    Schwarzenboeck SM; Rauscher I; Bluemel C; Fendler WP; Rowe SP; Pomper MG; Afshar-Oromieh A; Herrmann K; Eiber M
    J Nucl Med; 2017 Oct; 58(10):1545-1552. PubMed ID: 28687599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I Study of CTT1057, an
    Behr SC; Aggarwal R; VanBrocklin HF; Flavell RR; Gao K; Small EJ; Blecha J; Jivan S; Hope TA; Simko JP; Kurhanewicz J; Noworolski SM; Korn NJ; De Los Santos R; Cooperberg MR; Carroll PR; Nguyen HG; Greene KL; Langton-Webster B; Berkman CE; Seo Y
    J Nucl Med; 2019 Jul; 60(7):910-916. PubMed ID: 30464040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gallium-68 Prostate-Specific Membrane Antigen PET Imaging.
    Hofman MS; Iravani A
    PET Clin; 2017 Apr; 12(2):219-234. PubMed ID: 28267455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging.
    Sheikhbahaei S; Afshar-Oromieh A; Eiber M; Solnes LB; Javadi MS; Ross AE; Pienta KJ; Allaf ME; Haberkorn U; Pomper MG; Gorin MA; Rowe SP
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2117-2136. PubMed ID: 28765998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives.
    Zschaeck S; Lohaus F; Beck M; Habl G; Kroeze S; Zamboglou C; Koerber SA; Debus J; Hölscher T; Wust P; Ganswindt U; Baur ADJ; Zöphel K; Cihoric N; Guckenberger M; Combs SE; Grosu AL; Ghadjar P; Belka C
    Radiat Oncol; 2018 May; 13(1):90. PubMed ID: 29751842
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls.
    Sheikhbahaei S; Werner RA; Solnes LB; Pienta KJ; Pomper MG; Gorin MA; Rowe SP
    Semin Nucl Med; 2019 Jul; 49(4):255-270. PubMed ID: 31227049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging.
    Kabasakal L; Demirci E; Ocak M; Akyel R; Nematyazar J; Aygun A; Halac M; Talat Z; Araman A
    Nucl Med Commun; 2015 Jun; 36(6):582-7. PubMed ID: 25738559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligometastases in prostate cancer : Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT.
    Baumann R; Koncz M; Luetzen U; Krause F; Dunst J
    Strahlenther Onkol; 2018 Apr; 194(4):318-324. PubMed ID: 29181556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrence.
    Ferdinandus J; Fendler WP; Hadaschik B; Herrmann K
    Curr Opin Urol; 2020 Sep; 30(5):635-640. PubMed ID: 32732621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer.
    Afshar-Oromieh A; Babich JW; Kratochwil C; Giesel FL; Eisenhut M; Kopka K; Haberkorn U
    J Nucl Med; 2016 Oct; 57(Suppl 3):79S-89S. PubMed ID: 27694178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The future of choline PET in the era of prostate specific membrane antigen.
    Evangelista L; Cuppari L; Zattoni F; Mansi L; Bombardieri E
    Q J Nucl Med Mol Imaging; 2019 Mar; 63(1):19-28. PubMed ID: 29383928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 68Ga-Prostate-Specific Membrane Antigen-Avid Tubercular Lesions Mimicking Prostate Cancer Metastasis on Simultaneous Prostate-Specific Membrane Antigen PET/MRI.
    Ahuja A; Taneja S; Thorat K; Jena A
    Clin Nucl Med; 2017 Dec; 42(12):e509-e510. PubMed ID: 29036003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [
    Bauman G; Martin P; Thiessen JD; Taylor R; Moussa M; Gaed M; Rachinsky I; Kassam Z; Chin J; Pautler S; Lee TY; Valliant JF; Ward A
    Eur Urol Focus; 2018 Sep; 4(5):702-706. PubMed ID: 28753797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
    Weineisen M; Schottelius M; Simecek J; Baum RP; Yildiz A; Beykan S; Kulkarni HR; Lassmann M; Klette I; Eiber M; Schwaiger M; Wester HJ
    J Nucl Med; 2015 Aug; 56(8):1169-76. PubMed ID: 26089548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Rare Case of Omentum Invasive Prostate Cancer: Staging With PSMA PET/CT Imaging and Response to Systemic Therapy.
    Ladwa R; Gustafson S; McCaffrey E; Miles K; O'Byrne K
    Clin Nucl Med; 2017 Jun; 42(6):e311-e312. PubMed ID: 28240670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.